Literature DB >> 31392751

Maximum likelihood estimation with missing outcomes: From simplicity to complexity.

Stuart G Baker1.   

Abstract

Many clinical or prevention studies involve missing or censored outcomes. Maximum likelihood (ML) methods provide a conceptually straightforward approach to estimation when the outcome is partially missing. Methods of implementing ML methods range from the simple to the complex, depending on the type of data and the missing-data mechanism. Simple ML methods for ignorable missing-data mechanisms (when data are missing at random) include complete-case analysis, complete-case analysis with covariate adjustment, survival analysis with covariate adjustment, and analysis via propensity-to-be-missing scores. More complex ML methods for ignorable missing-data mechanisms include the analysis of longitudinal dropouts via a marginal model for continuous data or a conditional model for categorical data. A moderately complex ML method for categorical data with a saturated model and either ignorable or nonignorable missing-data mechanisms is a perfect fit analysis, an algebraic method involving closed-form estimates and variances. A complex and flexible ML method with categorical data and either ignorable or nonignorable missing-data mechanisms is the method of composite linear models, a matrix method requiring specialized software. Except for the method of composite linear models, which can involve challenging matrix specifications, the implementation of these ML methods ranges in difficulty from easy to moderate. Published 2019. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  composite linear model; double sampling; latent class instrumental variable; missing-data mechanism; perfect fit analysis; randomized trial

Year:  2019        PMID: 31392751      PMCID: PMC6879193          DOI: 10.1002/sim.8319

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  19 in total

1.  A graphical sensitivity analysis for clinical trials with non-ignorable missing binary outcome.

Authors:  Sally Hollis
Journal:  Stat Med       Date:  2002-12-30       Impact factor: 2.373

2.  A sensitivity analysis for nonrandomly missing categorical data arising from a national health disability survey.

Authors:  Stuart G Baker; Chia-Wen Ko; Barry I Graubard
Journal:  Biostatistics       Date:  2003-01       Impact factor: 5.899

3.  Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariates.

Authors:  Stuart G Baker; Garrett M Fitzmaurice; Laurence S Freedman; Barnett S Kramer
Journal:  Biostatistics       Date:  2005-05-27       Impact factor: 5.899

4.  Coronary heart disease risk factors in school children: the Muscatine study.

Authors:  R M Lauer; W E Connor; P E Leaverton; M A Reiter; W R Clarke
Journal:  J Pediatr       Date:  1975-05       Impact factor: 4.406

5.  Sensitivity analysis for a partially missing binary outcome in a two-arm randomized clinical trial.

Authors:  Victoria Liublinska; Donald B Rubin
Journal:  Stat Med       Date:  2014-05-20       Impact factor: 2.373

6.  Regression analysis of grouped survival data with incomplete covariates: nonignorable missing-data and censoring mechanisms.

Authors:  S G Baker
Journal:  Biometrics       Date:  1994-09       Impact factor: 2.571

7.  Transparency and reproducibility in data analysis: the Prostate Cancer Prevention Trial.

Authors:  Stuart G Baker; Amy K Darke; Paul Pinsky; Howard L Parnes; Barnett S Kramer
Journal:  Biostatistics       Date:  2010-02-19       Impact factor: 5.899

8.  Marginal regression for repeated binary data with outcome subject to non-ignorable non-response.

Authors:  S G Baker
Journal:  Biometrics       Date:  1995-09       Impact factor: 2.571

9.  A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A Study Team.

Authors:  K Henry; A Erice; C Tierney; H H Balfour; M A Fischl; A Kmack; S H Liou; A Kenton; M S Hirsch; J Phair; A Martinez; J O Kahn
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-12-01

10.  A simple method for analyzing data from a randomized trial with a missing binary outcome.

Authors:  Stuart G Baker; Laurence S Freedman
Journal:  BMC Med Res Methodol       Date:  2003-05-06       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.